[PDF][PDF] Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis

CJ Sinal, M Tohkin, M Miyata, JM Ward, G Lambert… - Cell, 2000 - cell.com
Mice lacking the nuclear bile acid receptor FXR/BAR developed normally and were
outwardly identical to wild-type littermates. FXR/BAR null mice were distinguished from wild-type …

The PCSK9 decade: thematic review series: new lipid and lipoprotein targets for the treatment of cardiometabolic diseases

G Lambert, B Sjouke, B Choque, JJP Kastelein… - Journal of lipid …, 2012 - ASBMB
PCSK9 proprotein convertase subtilisin/kexin type (PCSK9) is a crucial protein in LDL
cholesterol (LDL-C) metabolism by virtue of its pivotal role in the degradation of the LDL receptor. …

Lipoprotein metabolism in familial hypercholesterolemia

…, J García-Nafría, A Gallo, C Martín, G Lambert… - Journal of Lipid …, 2021 - ASBMB
Familial hypercholesterolemia (FH) is one of the most common genetic disorders in humans.
It is an extremely atherogenic metabolic disorder characterized by lifelong elevations of …

Hepatocyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis

GP Hayhurst, YH Lee, G Lambert, JM Ward… - … and cellular biology, 2001 - Taylor & Francis
The numerous functions of the liver are controlled primarily at the transcriptional level by the
concerted actions of a limited number of hepatocyte-enriched transcription factors (…

Inhibiting PCSK9—biology beyond LDL control

RM Stoekenbroek, G Lambert, B Cariou… - Nature Reviews …, 2019 - nature.com
Clinical trials have unequivocally shown that inhibition of proprotein convertase subtilisin/kexin
type 9 (PCSK9) efficaciously and safely prevents cardiovascular events by lowering …

Unravelling the functional significance of PCSK9

G Lambert - Current opinion in lipidology, 2007 - journals.lww.com
Mutations of PCSK9 are associated either with hypercholesterolemia or with hypocholesterolemia.
In the latter case, the incidence of coronary heart disease is reduced, thereby …

Lipoprotein (a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

…, MR Dweck, M Koschinsky, G Lambert… - European heart …, 2022 - academic.oup.com
This 2022 European Atherosclerosis Society lipoprotein(a) [Lp(a)] consensus statement
updates evidence for the role of Lp(a) in atherosclerotic cardiovascular disease (ASCVD) and …

Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes

K Matsusue, M Haluzik, G Lambert… - The Journal of …, 2003 - Am Soc Clin Investig
To elucidate the function of PPARγ in leptin-deficient mouse (ob/ob) liver, a PPARγ liver-null
mouse on an ob/ob background, ob/ob-PPARγ(fl/fl)AlbCre + , was produced using a floxed …

The farnesoid X-receptor is an essential regulator of cholesterol homeostasis

G Lambert, MJA Amar, G Guo, HB Brewer… - Journal of Biological …, 2003 - ASBMB
To address the importance of the farnesoid X-receptor (FXR; NR1H4) for normal cholesterol
homeostasis, we evaluated the major pathways of cholesterol metabolism in theFXR-…

HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells

…, CB Wiese, BM Shoucri, G Lambert… - Nature …, 2014 - nature.com
High-density lipoproteins (HDL) have many biological functions, including reducing endothelial
activation and adhesion molecule expression. We recently reported that HDL transport …